Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

1183 - Diagnostic performance of dedicated breast PET scanner with a ring detector


11 Sep 2017


Poster display session


Cancers in Adolescents and Young Adults (AYA);  Cancer Diagnostics;  Staging Procedures (not Imaging);  Translational Research;  Breast Cancer




Annals of Oncology (2017) 28 (suppl_5): v449-v452. 10.1093/annonc/mdx378


R. HASHIMOTO1, S. Akashi-Tanaka1, C. Watanabe1, H. Masuda1, K. Taruno1, T. Takamaru1, Y. Ide1, T. Kuwayama1, Y. Hirota2, Y. Kobayashi3, T. Sawada1, M. Hirose4, S. Nakamura1

Author affiliations

  • 1 Breast Surgical Oncology, SHOWA UNIVERSITY HOSPITAL, 1428666 - Tokyo/JP
  • 2 Pathology, SHOWA UNIVERSITY HOSPITAL, 1428666 - Tokyo/JP
  • 3 Radiology, Midtown clinic Tokyo bay, 1350063 - Tokyo/JP
  • 4 Radiology, SHOWA UNIVERSITY HOSPITAL, 1428666 - Tokyo/JP


Abstract 1183


Dedicated breast positron emission tomography scanners (dbPET) have been developed to make possible higher spatial resolution and sensitivity. The purpose of this study was to investigate the diagnostic performance of a dbPET scanner with an O-shaped detector in patients with known breast cancer.


A total of 82 female patients diagnosed with breast cancer consented to participate in this study (84 lesions: 10 ductal carcinomas in situ (DCIS), 74 invasive cancers). All patients underwent a WB-PET/MRI using Biograph mMR® (Siemens Healthcare) approximately 80 minutes after fluorine-18 fluorodeoxyglucose ((18)F-FDG;3.0MBq/kg) injection, followed by dbPET using Dedicated Breast PET System Elmammo®(Shimadzu, Kyoto, Japan) which required 5 minutes per breast.


The overall imaging sensitivities of dbPET and WB-PET/MRI were 89% (75/84) and 87% (74/84) respectively. The sensitivities excluding 5 lesions which were outside the field of view of dbPET, were 95% (75/79) and 87% (69/79) respectively. The standardized uptake values (SUV) of dbPET (SUVmax mean13, range 1.64-41.6) and WB-PET/MRI (SUVmax mean 5.71, range 1.15-13.3) showed correlation with nuclear grade (NG) (Spearman's rank-correlation coefficient r = 0.507, 0.455, p 


Both dbPET and WB-PET/MRI showed high imaging sensitivity, but dbPET had significantly higher sensitivity to high grade DCIS and invasive lesions up to 1cm. This level of diagnostic performance could help to detect early stage cancers as part of breast screening.

Clinical trial identification

We have registerd this trial at UMIN (Univresity Hospital Medical Information network) -CTR Serch Clinical Trials This trial protocol number of UMIN; UMIN000027227 (https://upload.umin.ac.jp/cgi-open-bin/ctr_e/index.cgi) Release date; 02.May.2017

Legal entity responsible for the study



Shimadzu corporation


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.